Skin Cancer

>

Latest News

Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 Therapy
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 Therapy

March 26th 2024

Rates, Incidence of Skin Cancer Found to be Higher in Patients With Skin of Color and in Rural Communities
Rates, Incidence of Skin Cancer Found to be Higher in Patients With Skin of Color and in Rural Communities

March 21st 2024

Skin Cancer and COVID-19: Research and Links Between Diagnosis and the Pandemic
Skin Cancer and COVID-19: Research and Links Between Diagnosis and the Pandemic

March 20th 2024

Robert Den, MD: Exploring the Potential of Alpha DaRT in Skin Cancer
Robert Den, MD: Exploring the Potential of Alpha DaRT in Skin Cancer

March 19th 2024

Video Interviews
Podcasts
 The Cutaneous Connection
 The Cutaneous Connection: Episode 27
The Cutaneous Connection
The Cutaneous Connection

More News

© 2024 MJH Life Sciences

All rights reserved.